Evidence map›Paper›PMID 42328490›Full record

ArticleClinical, cosmetic and investigational dermatology2026

Operational Standard for Tissue-Extracted Collagen Facial Injection Techniques.

Yinjie Ao, Xiaoyang Wang, Bing Shi

Abstract read
In one paragraph

Article in Clinical, cosmetic and investigational dermatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Yinjie AoDepartment of Plastic Surgery and Medical Cosmetic Center, The Affiliated Eye Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, People's Republic of China.
Xiaoyang WangShanghai Yanfan Medical Cosmetic Clinic, Shanghai, People's Republic of China.
Bing ShiChinese Association of Plastics and Aesthetics, Beijing, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Since its first approval in 1981, tissue-extracted collagen injection technology has become an important method for minimally invasive facial rejuvenation, with substantial clinical experience accumulated particularly in the periorbital area. However, due to significant differences in physicochemical properties and metabolic mechanisms compared to hyaluronic acid, its clinical application still faces limitations in understanding and unique complication risks. Furthermore, no unified technical operating standards currently exist internationally. Methods: This standard is based on a synthesis of multicenter expert clinical experience. It systematically outlines the product characteristics, classification, and specifications of tissue-extracted collagen; defines clinical indications, contraindications, and operational precautions; specifies qualification requirements for medical institutions and operating physicians; establishes protocols for pre-operative assessment, regional injection design, post-operative management, and complication prevention and treatment strategies; and proposes multimodal treatment recommendations combining surgery, thread lifting, energy-based devices, and other fillers. Clinical Recommendations: Through standardized operating procedures and layered injection techniques, the safety and efficacy of tissue-extracted collagen injection therapy can be effectively improved, reducing the occurrence of complications such as nodules and vascular embolism. Combined treatment strategies further expand the application of collagen in facial rejuvenation, achieving complementary effects and optimizing recovery periods. Conclusion: This operational standard provides systematic and standardized clinical guidance for tissue-extracted collagen facial injection. It contributes to promoting the appropriate application and healthy development of this technology, enhancing overall treatment quality and patient satisfaction.

Indexed as

combination therapycomplication prevention and managementfacial rejuvenationoperational standardtissue-extracted collagen

Identifiers

PMID42328490
PMCPMC13282991

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.